APO Research
Talk to an analyst

APO RESEARCH · REPORT

Eldecalcitol API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Eldecalcitol API Market Outlook and Growth Opportunities 2026

29 December 2025198 pages

Choose your research edition.

Industry ResearchEldecalcitol API Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Eldecalcitol API Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Eldecalcitol API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eldecalcitol API Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Eldecalcitol API Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Eldecalcitol API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Eldecalcitol API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Eldecalcitol API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Eldecalcitol API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Eldecalcitol API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Eldecalcitol API market include Dongling Pharmaceutical Technology (Liaoning) Co., Ltd., Duoduo Pharmaceutical Co., Ltd., Heilongjiang Huimeijia Pharmaceutical Co., Ltd., Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. and Liaoning Xingao Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Eldecalcitol API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Eldecalcitol API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Eldecalcitol API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Eldecalcitol API market size, projected growth trends, production technologies, key applications, and end-use industries.

Eldecalcitol API Segment by Company

Dongling Pharmaceutical Technology (Liaoning) Co., Ltd.

Duoduo Pharmaceutical Co., Ltd.

Heilongjiang Huimeijia Pharmaceutical Co., Ltd.

Heilongjiang Wusulijiang Pharmaceutical Co., Ltd.

Liaoning Xingao Pharmaceutical Co., Ltd.

Eldecalcitol API Segment by Type

10ml

20ml

Eldecalcitol API Segment by Application

Hospital

Clinic

Other

Eldecalcitol API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Eldecalcitol API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Eldecalcitol API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Eldecalcitol API significant trends, drivers, influence factors in global and regions.

6. To analyze Eldecalcitol API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eldecalcitol API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eldecalcitol API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eldecalcitol API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Eldecalcitol API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Eldecalcitol API industry.

Chapter 3: Detailed analysis of Eldecalcitol API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Eldecalcitol API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Eldecalcitol API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Eldecalcitol API Industry Trends Table 2. Eldecalcitol API Industry Drivers Table 3. Eldecalcitol API Industry Opportunities and Challenges Table 4. Eldecalcitol API Industry Restraints Table 5. Global Eldecalcitol API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Eldecalcitol API Revenue Share by Company (2021-2026) Table 7. Global Eldecalcitol API Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Eldecalcitol API Sales Volume Share by Company (2021-2026) Table 9. Global Eldecalcitol API Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Eldecalcitol API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Eldecalcitol API Key Company Manufacturing Base & Headquarters Table 12. Global Eldecalcitol API Company, Product Type & Application Table 13. Global Eldecalcitol API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Eldecalcitol API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10ml Table 18. Significant Companies of 20ml Table 19. Global Eldecalcitol API Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Eldecalcitol API Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Eldecalcitol API Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Eldecalcitol API Sales Volume Share by Type (2021-2026) Table 23. Global Eldecalcitol API Sales Volume Share by Type (2027-2032) Table 24. Global Eldecalcitol API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Eldecalcitol API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Eldecalcitol API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Eldecalcitol API Sales Value Share by Type (2021-2026) Table 28. Global Eldecalcitol API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Eldecalcitol API Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Eldecalcitol API Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Eldecalcitol API Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Eldecalcitol API Sales Volume Share by Application (2021-2026) Table 36. Global Eldecalcitol API Sales Volume Share by Application (2027-2032) Table 37. Global Eldecalcitol API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Eldecalcitol API Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Eldecalcitol API Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Eldecalcitol API Sales Value Share by Application (2021-2026) Table 41. Global Eldecalcitol API Sales Value Share by Application (2027-2032) Table 42. Global Eldecalcitol API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Eldecalcitol API Sales by Region (2021-2026) & (K Units) Table 44. Global Eldecalcitol API Sales Market Share by Region (2021-2026) Table 45. Global Eldecalcitol API Sales by Region (2027-2032) & (K Units) Table 46. Global Eldecalcitol API Sales Market Share by Region (2027-2032) Table 47. Global Eldecalcitol API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Eldecalcitol API Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Eldecalcitol API Sales Value Share by Region (2021-2026) Table 50. Global Eldecalcitol API Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Eldecalcitol API Sales Value Share by Region (2027-2032) Table 52. Global Eldecalcitol API Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Eldecalcitol API Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Eldecalcitol API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Eldecalcitol API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Eldecalcitol API Sales by Country (2021-2026) & (K Units) Table 57. Global Eldecalcitol API Sales Market Share by Country (2021-2026) Table 58. Global Eldecalcitol API Sales by Country (2027-2032) & (K Units) Table 59. Global Eldecalcitol API Sales Market Share by Country (2027-2032) Table 60. Global Eldecalcitol API Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Eldecalcitol API Sales Value Market Share by Country (2021-2026) Table 62. Global Eldecalcitol API Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Eldecalcitol API Sales Value Market Share by Country (2027-2032) Table 64. Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Company Information Table 65. Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Business Overview Table 66. Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Eldecalcitol API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Eldecalcitol API Product Portfolio Table 68. Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Recent Development Table 69. Duoduo Pharmaceutical Co., Ltd. Company Information Table 70. Duoduo Pharmaceutical Co., Ltd. Business Overview Table 71. Duoduo Pharmaceutical Co., Ltd. Eldecalcitol API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Duoduo Pharmaceutical Co., Ltd. Eldecalcitol API Product Portfolio Table 73. Duoduo Pharmaceutical Co., Ltd. Recent Development Table 74. Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Company Information Table 75. Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Business Overview Table 76. Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Eldecalcitol API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Eldecalcitol API Product Portfolio Table 78. Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Recent Development Table 79. Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Company Information Table 80. Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Business Overview Table 81. Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Eldecalcitol API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Eldecalcitol API Product Portfolio Table 83. Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Recent Development Table 84. Liaoning Xingao Pharmaceutical Co., Ltd. Company Information Table 85. Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview Table 86. Liaoning Xingao Pharmaceutical Co., Ltd. Eldecalcitol API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Liaoning Xingao Pharmaceutical Co., Ltd. Eldecalcitol API Product Portfolio Table 88. Liaoning Xingao Pharmaceutical Co., Ltd. Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Eldecalcitol API Distributors List Table 92. Eldecalcitol API Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Eldecalcitol API Product Image Figure 2. Global Eldecalcitol API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eldecalcitol API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Eldecalcitol API Sales (2021-2032) & (K Units) Figure 5. Global Eldecalcitol API Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Eldecalcitol API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10ml Image Figure 10. 20ml Image Figure 11. Global Eldecalcitol API Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Eldecalcitol API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Eldecalcitol API Sales Volume Share by Type (2021-2032) Figure 14. Global Eldecalcitol API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Eldecalcitol API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Eldecalcitol API Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Eldecalcitol API Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Eldecalcitol API Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Eldecalcitol API Sales Volume Share by Application (2021-2032) Figure 23. Global Eldecalcitol API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Eldecalcitol API Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Eldecalcitol API Sales Value Share by Application (2021-2032) Figure 26. Global Eldecalcitol API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Eldecalcitol API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Eldecalcitol API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Eldecalcitol API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Eldecalcitol API Sales Value (2021-2032) & (US$ Million) Figure 31. North America Eldecalcitol API Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Eldecalcitol API Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Eldecalcitol API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Eldecalcitol API Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Eldecalcitol API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Eldecalcitol API Sales Value (2021-2032) & (US$ Million) Figure 37. South America Eldecalcitol API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Eldecalcitol API Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Eldecalcitol API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Eldecalcitol API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Eldecalcitol API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Eldecalcitol API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Eldecalcitol API Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Eldecalcitol API Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml
  • 20ml
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Dongling Pharmaceutical Technology (Liaoning) Co., Ltd.
  • Duoduo Pharmaceutical Co., Ltd.
  • Heilongjiang Huimeijia Pharmaceutical Co., Ltd.
  • Heilongjiang Wusulijiang Pharmaceutical Co., Ltd.
  • Liaoning Xingao Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Eldecalcitol API Sales Value (2021-2032)
  4. 1.2.2 Global Eldecalcitol API Sales Volume (2021-2032)
  5. 1.2.3 Global Eldecalcitol API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Eldecalcitol API Market Dynamics
  1. 2.1 Eldecalcitol API Industry Trends
  2. 2.2 Eldecalcitol API Industry Drivers
  3. 2.3 Eldecalcitol API Industry Opportunities and Challenges
  4. 2.4 Eldecalcitol API Industry Restraints
3 Eldecalcitol API Market by Company
  1. 3.1 Global Eldecalcitol API Company Revenue Ranking in 2025
  2. 3.2 Global Eldecalcitol API Revenue by Company (2021-2026)
  3. 3.3 Global Eldecalcitol API Sales Volume by Company (2021-2026)
  4. 3.4 Global Eldecalcitol API Average Price by Company (2021-2026)
  5. 3.5 Global Eldecalcitol API Company Ranking (2024-2026)
  6. 3.6 Global Eldecalcitol API Company Manufacturing Base and Headquarters
  7. 3.7 Global Eldecalcitol API Company Product Type and Application
  8. 3.8 Global Eldecalcitol API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Eldecalcitol API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Eldecalcitol API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Eldecalcitol API Market by Type
  1. 4.1 Eldecalcitol API Type Introduction
  2. 4.1.1 10ml
  3. 4.1.2 20ml
  4. 4.2 Global Eldecalcitol API Sales Volume by Type
  5. 4.2.1 Global Eldecalcitol API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Eldecalcitol API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Eldecalcitol API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Eldecalcitol API Sales Value by Type
  9. 4.3.1 Global Eldecalcitol API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Eldecalcitol API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Eldecalcitol API Sales Value Share by Type (2021-2032)
5 Eldecalcitol API Market by Application
  1. 5.1 Eldecalcitol API Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Eldecalcitol API Sales Volume by Application
  6. 5.2.1 Global Eldecalcitol API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Eldecalcitol API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Eldecalcitol API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Eldecalcitol API Sales Value by Application
  10. 5.3.1 Global Eldecalcitol API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Eldecalcitol API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Eldecalcitol API Sales Value Share by Application (2021-2032)
6 Eldecalcitol API Regional Sales and Value Analysis
  1. 6.1 Global Eldecalcitol API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Eldecalcitol API Sales by Region (2021-2032)
  3. 6.2.1 Global Eldecalcitol API Sales by Region: 2021-2026
  4. 6.2.2 Global Eldecalcitol API Sales by Region (2027-2032)
  5. 6.3 Global Eldecalcitol API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Eldecalcitol API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Eldecalcitol API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Eldecalcitol API Sales Value by Region (2027-2032)
  9. 6.5 Global Eldecalcitol API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Eldecalcitol API Sales Value (2021-2032)
  12. 6.6.2 North America Eldecalcitol API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Eldecalcitol API Sales Value (2021-2032)
  15. 6.7.2 Europe Eldecalcitol API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Eldecalcitol API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Eldecalcitol API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Eldecalcitol API Sales Value (2021-2032)
  21. 6.9.2 South America Eldecalcitol API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Eldecalcitol API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Eldecalcitol API Sales Value Share by Country, 2025 VS 2032
7 Eldecalcitol API Country-level Sales and Value Analysis
  1. 7.1 Global Eldecalcitol API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Eldecalcitol API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Eldecalcitol API Sales by Country (2021-2032)
  4. 7.3.1 Global Eldecalcitol API Sales by Country (2021-2026)
  5. 7.3.2 Global Eldecalcitol API Sales by Country (2027-2032)
  6. 7.4 Global Eldecalcitol API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Eldecalcitol API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Eldecalcitol API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Eldecalcitol API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Eldecalcitol API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Eldecalcitol API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Eldecalcitol API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Eldecalcitol API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Eldecalcitol API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Eldecalcitol API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Eldecalcitol API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Eldecalcitol API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Eldecalcitol API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Eldecalcitol API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Eldecalcitol API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Eldecalcitol API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Eldecalcitol API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Eldecalcitol API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Eldecalcitol API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Eldecalcitol API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Eldecalcitol API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Eldecalcitol API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Eldecalcitol API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Eldecalcitol API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Eldecalcitol API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Eldecalcitol API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Eldecalcitol API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Eldecalcitol API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Eldecalcitol API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Eldecalcitol API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Eldecalcitol API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Eldecalcitol API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Eldecalcitol API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Dongling Pharmaceutical Technology (Liaoning) Co., Ltd.
  2. 8.1.1 Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Company Information
  3. 8.1.2 Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Business Overview
  4. 8.1.3 Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Eldecalcitol API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Eldecalcitol API Product Portfolio
  6. 8.1.5 Dongling Pharmaceutical Technology (Liaoning) Co., Ltd. Recent Developments
  7. 8.2 Duoduo Pharmaceutical Co., Ltd.
  8. 8.2.1 Duoduo Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Duoduo Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Duoduo Pharmaceutical Co., Ltd. Eldecalcitol API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Duoduo Pharmaceutical Co., Ltd. Eldecalcitol API Product Portfolio
  12. 8.2.5 Duoduo Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Heilongjiang Huimeijia Pharmaceutical Co., Ltd.
  14. 8.3.1 Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Eldecalcitol API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Eldecalcitol API Product Portfolio
  18. 8.3.5 Heilongjiang Huimeijia Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Heilongjiang Wusulijiang Pharmaceutical Co., Ltd.
  20. 8.4.1 Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Eldecalcitol API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Eldecalcitol API Product Portfolio
  24. 8.4.5 Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Liaoning Xingao Pharmaceutical Co., Ltd.
  26. 8.5.1 Liaoning Xingao Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Liaoning Xingao Pharmaceutical Co., Ltd. Eldecalcitol API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Liaoning Xingao Pharmaceutical Co., Ltd. Eldecalcitol API Product Portfolio
  30. 8.5.5 Liaoning Xingao Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Eldecalcitol API Value Chain Analysis
  2. 9.1.1 Eldecalcitol API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Eldecalcitol API Sales Mode & Process
  6. 9.2 Eldecalcitol API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Eldecalcitol API Distributors
  9. 9.2.3 Eldecalcitol API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst